tirzepatide fda approval 2022 What happens next following of Mounjaro® from Eli Lilly for diabetes? Utilization Trends of Dual GIP/GLP-1
Description
GLP-1 receptor agonist drugs (e.g., semaglutide, liraglutide, tirzapeptide) work by mimicking natural GLP-1 but last much longer
Clinical trial data consistently shows tirzepatide producing greater average weight loss than semaglutide, though individual results vary widely
The medication acts on areas of the brain involved in appetite control, leading to reduced hunger and increased feelings of fullness
Deamidation rates increase with temperature and also depend on pH and the sequence of neighboring amino acids
GLP-1R and GIPR belong to class B1 of the G protein-coupled receptors, and share high homology and a similar action pattern
